IDEXX LaboratoriesFRA:IX1 -0.19%96 Median PS Value is €501.68 as of Jun. 25, 2026, which is 100% below its 10-year median of 1.71. GuruFocus rates FRA:IX1 with a GF Score™ of 96/100 and a GF Value™ of €544.17 (Modestly Undervalued). Among 86 Medical Diagnostics & Research companies, IDEXX Laboratories ranks worse than 58.14% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for IDEXX Laboratories's Median PS Value or its related term are showing as below:
FRA:IX1'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.89 Med: 1.71 Max: 3.1
Current: 0.94
During the past 13 years, the highest Price to Median PS Value of IDEXX Laboratories was 3.10. The lowest was 0.89. And the median was 1.71.
FRA:IX1's Price-to-Median-PS-Value is ranked worse than 58.14% of 86
companies
in the Medical Diagnostics & Research industry
Industry Median: 0.87
vs FRA:IX1: 0.94
IDEXX Laboratories (FRA:IX1) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
IDEXX Laboratories's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
473.80
/
501.68
=
0.94
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IDEXX Laboratories Median PS Value Related Terms
IDEXX Laboratories Median PS Value Historical Data
* Premium members only.
The historical data trend for IDEXX Laboratories's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:IX1 vs A, WAT, NTRA: Median PS Value Comparison
For the Diagnostics & Research subindustry, IDEXX Laboratories's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IDEXX Laboratories Price-to-Median-PS-Value vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, IDEXX Laboratories's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where IDEXX Laboratories's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 10.577.
IDEXX Laboratories's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €47.431.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IDEXX Laboratories (FRA:IX1) has a Median PS Value of €501.68 as of Jun. 25, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on IDEXX Laboratories and its competitors. This is 29238% above median its historical median of 1.71. Over the past decade, IDEXX Laboratories' Median PS Value has ranged from 0.89 to 3.10. According to the industry distribution chart, IDEXX Laboratories ranks #50 out of 86 companies in the Medical Diagnostics & Research industry, placing it in the top 58.1%.
Is IDEXX Laboratories' Median PS Value too high?
IDEXX Laboratories' current Median PS Value of €501.68 is 29238% above median its 10-year median of 1.71. Over the past 10 years, this metric has ranged from a low of 0.89 to a high of 3.10. Based on the distribution chart, IDEXX Laboratories ranks #50 out of 86 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, IDEXX Laboratories has a GF Score™ of 96/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does IDEXX Laboratories' Median PS Value compare to A and WAT?
According to the Medical Diagnostics & Research industry distribution chart, IDEXX Laboratories ranks #50 out of 86 companies for Median PS Value. This places IDEXX Laboratories in the lower half of its industry. The industry median Median PS Value is 0.87. Historically, IDEXX Laboratories' own Median PS Value has ranged from 0.89 to 3.10 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Medical Diagnostics & Research company?
The median Median PS Value among Medical Diagnostics & Research companies is 0.87, based on 86 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on IDEXX Laboratories and its competitors. For the Medical Diagnostics & Research industry, the median Median PS Value is 0.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IDEXX Laboratories's current Median PS Value is €501.68, which is 29238% above median its own 10-year median of 1.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IDEXX Laboratories stock overvalued right now?
Based on GuruFocus' analysis, IDEXX Laboratories (FRA:IX1) is currently considered Modestly Undervalued. The stock's GF Value™ is €544.17, compared to a current price of €473.80 — trading 12.9% below its estimated fair value. The current Median PS Value is €501.68, which is 29238% above median its 10-year median of 1.71. IDEXX Laboratories' overall GF Score™ is 96/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For IDEXX Laboratories (FRA:IX1), the current Median PS Value is €501.68 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is IDEXX Laboratories (FRA:IX1) Overvalued in 2026?
Based on GuruFocus' analysis, IDEXX Laboratories stock appears to be undervalued.
The current stock price of €473.80 is trading 12.9% below its estimated GF Value™ of €544.17.
GuruFocus considers IDEXX Laboratories to be Modestly Undervalued.
Key valuation signals for FRA:IX1:
Median PS Value: €501.68 (29238% above median its 10-year median of 1.71)
GF Value™: €544.17 vs. price of €473.80 (12.9% below fair value)
No single metric tells the full story. See the FRA:IX1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.
96GF Score
Get the complete analysis for FRA:IX1
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:IX1 has been successfully added to your 
